NEW YORK, June 28 - Denise Gilbert, the new CEO of bioinformatics company Entigen, hopes to extend the company's middleware for integrating data across the continuum of genomics to clinical disease management, she told GenomeWeb Thursday.

Entigen, formed in December 2000 from the merger of eBioinformatics and Empatheon, is looking to provide a combination of products and services to customers in non-profit research institutions, and pharmaceutical and biotechnology companies, she said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.